The emerging therapy of this peptide represents a significant development in the management of type 2 diabetes. Different to existing medications, tirzepatide impacts two pathways – GLP-1 and GIP – leading to https://tirzepatide-peptide366893.blog2news.com/42536372/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment